Financial Incentives to Encourage Development of Therapies That Address Unmet Medical Needs for Nervous System Disorders Workshop Summary (2015) / Chapter Skim
Currently Skimming:
Appendix D: Participant Biographies
Appendix D: Participant Biographies
Pages 87-114
The Chapter Skim interface presents what we've algorithmically identified as the most significant single chunk of text within every page in the chapter.
Select key terms on the right to highlight them within pages of the chapter.
From page 87... ...
; a member of the National Institutes of Health National Center for Advancing Translational Sciences Advisory Council and Cures Acceleration Network Review Board, the National Health Council Board of Directors, United for Medical Research Steering Committee, 87
|
From page 88... ...
and the Association of Corporate Patent Counsel. Other leadership positions include service as chair of the following organizations: the American Bar Association Intellectual Property Law Section, the National Council of Intellectual Property Law Associations, the Fellows of the American Intellectual Property Law Association, the Patent Committee of the Pharmaceutical Research and Manufacturers of America (PhRMA)
|
From page 89... ...
patent law in the past 175 years. Marc Boutin, J.D., is the executive vice president and chief operating officer of the National Health Council, an organization that brings together all segments of the health care community to provide a united voice for the more than 133 million people with chronic diseases and disabilities and their family caregivers.
|
From page 90... ...
Dennis Choi, M.D., Ph.D., is professor and chair of the Department of Neurology and director of the Neurosciences Institute at Stony Brook University, as well as director of the Brain Sciences Institute at the Korea Institute of Science and Technology. Prior positions have included executive vice president at the Simons Foundation, vice president for Academic Health Affairs at Emory University, executive vice president for Neuroscience at Merck Research Labs, and head of neurology at Washington University Medical School.
|
From page 91... ...
in Molecular Biology from Albany Medical College in 1993 and has since been involved in the field of multiple sclerosis research. Adelina Comas-Herrera is a current Research Fellow at the London School of Economics and Political Science and also serves as the academic project manager of the Modelling Dementia (MODEM)
|
From page 92... ...
Alfred B Engelberg, J.D., is an intellectual property lawyer.
|
From page 93... ...
Fox Foundation for Parkinson's Research, where he co-manages a team of research professionals who stay closely linked to the research community in order to develop an aggressive and innovative agenda for accelerating research and drug development for Parkinson's disease. This ensures that research priorities reflect and best serve the ultimate needs of patients.
|
From page 94... ...
Before joining the SAGE team, he served as president of the Regenerative Medicine Division of Shire Plc and previously as senior vice president of research and development, Pharmaceuticals at Shire. Earlier, he served as executive vice president of ISIS Pharmaceuticals; as chief medical officer and executive vice president of Forest Laboratories, Inc.; and in senior-level positions at Upjohn Laboratories.
|
From page 95... ...
. His research focuses on the effects of intellectual property laws and regulatory policies on pharmaceutical development, the drug approval process, and the costs, availability, and use of prescription drugs both domestically and in resource-poor settings.
|
From page 96... ...
Dr. Kesselheim also is a faculty supervisor for the Petrie-Flom Center for Health Law Policy, Biotechnology, and Bioethics at Harvard Law School, the Harvard Center for Bioethics, and is a research associate in the Department of Health Policy and Management at the Harvard School of Public Health.
|
From page 97... ...
He has held leadership roles in a number of the National Institutes of Health (NIH) and NINDS programs, including NIH's BRAIN Initiative, the Traumatic Brain Injury Center collaborative effort between the NIH intramural program and the Uniformed Services University of the Health Sciences, and the multiyear effort to develop and establish the NIH Office of Emergency Care Research to coordinate research and research training.
|
From page 98... ...
He has served as an ethics expert in consultations with numerous national and international organizations, including the National Institutes of Health, the World Health Organization, the World Medical Association, and the World Bank. Raj Long, M.S., M.Sc., is a senior executive with more than 20 years of experience in the pharmaceutical industry.
|
From page 99... ...
Until 2009, Mr. Longman was managing director, pharma at Elsevier Business Intelligence, a Reed Elsevier company.
|
From page 100... ...
Mr. Manetto manages client teams and projects focused on health care delivery and payment models, biomedical research, drug development, and public health.
|
From page 101... ...
Patent and Trademark Office, and is a member of American Intellectual Property Law Association and the American Bar Association. She serves on the pro bono committee for Cooley's Washington, DC, office and is actively involved in various pro bono matters.
|
From page 102... ...
She also chairs the Arthritis Foundation and Arthritis Industry Forum and sits on multiple corporate advisory councils for national and international advocacy organizations. In 2013, she was appointed to the Board of Directors of Green Door, a Washington, DC, community mental health center.
|
From page 103... ...
Paul was the founding director of the Appel Alzheimer's Disease Research Institute, where he was the Principal Investigator of the Institute's novel adeno-associated virus gene therapy program for Alzheimer's disease, as well as professor of neuroscience, psychiatry, and pharmacology at Weill Cornell Medical College. Earlier, he spent 17 years at Eli Lilly, during which time he held several key leadership roles, including president of the Lilly Research Laboratories and vice president of discovery research and neuroscience research.
|
From page 104... ...
She is the editor of Intellectual Property Law and Biotechnology: Critical Concepts (Edward Elgar, 2011) and the coauthor of a 2012 Kauffman Foundation monograph on cost-effective health care innovation.
|
From page 105... ...
She graduated from Harvard College, magna cum laude, with a degree in Biochemistry and History (History and Science) , attended Harvard Medical School for 1 year, and received her J.D., cum laude, from Harvard Law School.
|
From page 106... ...
Prior to joining Autism Speaks, Dr. Ring served as senior director and head of the Autism Research Unit at Pfizer Worldwide Research and Development in Groton, Connecticut.
|
From page 107... ...
Dr. Robinson Beale has worked as a chief medical officer/physician executive for behavioral and medical in her work with several large national and local health care organizations, such as Optum, a subsidiary within UnitedHealth Group, PacifiCare, Cigna, Blue Cross Blue Shield of Michigan, and Health Alliance Plan.
|
From page 108... ...
Prior to joining the Sloan faculty in 2014, Roin was the Hieken Assistant Professor of Patent Law at Harvard Law School, where he taught courses on patent law, trade secrecy, and torts. Before joining the Harvard Law School faculty in 2008, he was an Academic Fellow at the Petrie-Flom Center at Harvard Law School, and clerked for Judge Michael McConnell on the U.S.
|
From page 109... ...
, a nonprofit organization composed of some of the United States' leading professional neurological, psychological, and psychiatric associations and patient organizations. ABC seeks to advance the understanding of the functions of the brain and to reduce the burden of brain disorders through public advocacy.
|
From page 110... ...
Maike Stenull, M.B.A., is the senior director, strategic projects and transformational leadership at the Office of the Chief Medical Officer at Johnson & Johnson (J&J)
|
From page 111... ...
In that role he also served as psychiatrist-in-chief of the North Shore Medical Center, where he was executive vice president for medical affairs and chief medical officer and a member of the Partners Executive Committee. A 1978, Alpha Omega Alpha graduate of the School of Medicine at the State University of New York of Buffalo, he trained in internal medicine at the Boston City Hospital from 1978–1981 and in psychiatry at the Massachusetts General Hospital from 1982–1985 where he was chief resident.
|
From page 112... ...
The Roundtable provides a unique forum for senior scientists from the pharmaceutical industry, biotech, imaging, academia, the National Institutes of Health, and regulatory agencies to discuss common issues and obstacles in Alzheimer's disease research and drug development. Before joining the Alzheimer's Association, Dr.
|
From page 113... ...
from Oberlin College, magna cum laude, and his J.D. from Harvard Law School, cum laude.
|
From page 114... ...
From 2005 until 2008, she served as FDA's commissioner, holding several positions, including deputy commissioner and chief medical officer, deputy commissioner for operations, and chief operating officer. Her responsibilities involved oversight of various aspects of scientific and medical regulatory operations.
|
Key Terms
This material may be derived from roughly machine-read images, and so is provided only to facilitate research.
More
information on Chapter Skim is available.